SCHEMBL13018665

SCHEMBL13018665

Nc1nccc(N2CC3(CCNCC3)C2)n1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 7/20 0.65
▸ ALDH1A1 P00352 8/20 0.57
▸ HSD17B10 Q99714 7/20 0.57
▸ CYP1A2 P05177 5/20 0.57
▸ HPGD P15428 4/20 0.57
▸ HRH4 Q9H3N8 1/20 0.49
▸ TSHR P16473 6/20 0.45
▸ CYP2D6 P10635 8/20 0.45
▸ CYP3A4 P08684 5/20 0.45
▸ USP2 O75604 4/20 0.45
▸ CYP2C9 P11712 3/20 0.45
▸ CYP2C19 P33261 3/20 0.45
▸ MAPK1 P28482 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TP53 P04637 2/20 0.41
▸ ROCK1 Q13464 2/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13018670 0.87 HRH3 (0.76) HRH3ALDH1A1HSD17B10CYP1A2HPGD
SCHEMBL2167882 0.79 HRH3 (1.00) HRH3ALDH1A1HSD17B10CYP1A2HRH4
SCHEMBL27226470 0.78 ALDH1A1 (0.54) HRH3ALDH1A1HSD17B10CYP1A2HPGD
Hydrochloric Acid SCHEMBL3781500 0.78 HRH3 (0.97) HRH3ALDH1A1HSD17B10CYP1A2HRH4
Hydrochloric Acid SCHEMBL26600058 0.78 HRH3 (0.97) HRH3ALDH1A1HSD17B10CYP1A2HRH4
SCHEMBL2166795 0.76 HRH3 (1.00) HRH3ALDH1A1HSD17B10HPGDHRH4
SCHEMBL13018739 0.75 HRH3 (0.60) HRH3ALDH1A1HSD17B10HPGDHRH4
SCHEMBL29946786 0.75 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP1A2HPGDTSHR
Hydrochloric Acid SCHEMBL3786113 0.75 HRH3 (0.97) HRH3ALDH1A1HSD17B10HPGDHRH4
SCHEMBL13018668 0.74 HRH3 (0.88) HRH3ALDH1A1HSD17B10CYP1A2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796297-B2 4-substituted-2-amino-pyrimidine derivatives ABBVIE INC. (US) 2014-08-05 — — US disclosed
US-8796297-B2 4-substituted-2-amino-pyrimidine derivatives ABBVIE INC. (US) 2014-08-05 — — US disclosed
US-20100331294-A1 4-SUBSTITUTED-2-AMINO-PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2010-12-30 — — US disclosed
US-20100331294-A1 4-SUBSTITUTED-2-AMINO-PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2010-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331294-A1 4-SUBSTITUTED-2-AMINO-PYRIMIDINE DERIVATIVES HRH2, HRH4, HRH3 HRH3 3/4885ALDH1A1 1078/4885HSD17B10 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback